Descargar PDF

Otros usuarios también vieron estos artículos

Frailty in end stage renal disease: Current perspectives Shankar Prasad Nagaraju, Srinivas Vinayak Shenoy, Ankur Gupta
10.1016/j.nefro.2021.05.011
Is just enzyme replacement therapy enough for Fabry disease treatment? Have we missed a trick? Hakan Ozer, Ismail Baloglu, Ali Topkac, Yasin Ozturk, Fethi Yonet, Furkan Daglı, İbrahim Kilinc, Kultigin Turkmen
10.1016/j.nefro.2023.01.002
D313Y variant in two related end-stage renal disease patients – Pathogenic or not yet? Rita Vicente, Iolanda Santos, Miguel Coimbra, Joana Santos, Ricardo Santos, Manuel Amoedo, Carlos Pires
10.1016/j.nefro.2022.01.002